Published in PLoS One on June 28, 2010
Harnessing local and systemic immunity for vaccines against tuberculosis. Mucosal Immunol (2013) 0.95
Simultaneous immunization against tuberculosis. PLoS One (2011) 0.90
The impact of transcriptomics on the fight against tuberculosis: focus on biomarkers, BCG vaccination, and immunotherapy. Clin Dev Immunol (2010) 0.88
Evidence for a role for interleukin-17, Th17 cells and iron homeostasis in protective immunity against tuberculosis in cynomolgus macaques. PLoS One (2014) 0.88
Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers. PLoS One (2012) 0.87
Identification of surrogates of protection against yersiniosis in immersion vaccinated Atlantic salmon. PLoS One (2012) 0.82
Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A. Vaccine (2012) 0.81
A novel murine cytomegalovirus vaccine vector protects against Mycobacterium tuberculosis. J Immunol (2014) 0.80
Pentraxin 3: an immuno-regulator in the lungs. Front Immunol (2013) 0.79
Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy. Vaccine (2013) 0.78
Differential transcriptomic response in the spleen and head kidney following vaccination and infection of Asian seabass with Streptococcus iniae. PLoS One (2014) 0.78
Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis. BMC Bioinformatics (2016) 0.77
Development of an unbiased antigen-mining approach to identify novel vaccine antigens and diagnostic reagents for bovine tuberculosis. Clin Vaccine Immunol (2013) 0.76
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet (2001) 13.79
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol (2007) 10.71
Granules of the human neutrophilic polymorphonuclear leukocyte. Blood (1997) 5.07
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med (2008) 4.21
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (1992) 3.96
Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science (2009) 3.71
Evidence for a cross-talk between human neutrophils and Th17 cells. Blood (2009) 2.75
Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun (2000) 2.63
Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun (2009) 2.57
IL-23 and IL-17 in tuberculosis. Cytokine (2008) 2.35
The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol (1997) 2.18
Matrix metalloproteinases in destructive pulmonary pathology. Thorax (2005) 2.06
Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun (2006) 1.75
The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol (2005) 1.71
Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle. Vet J (2004) 1.69
The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig. J Immunol (2007) 1.61
DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun (2007) 1.60
T cell-dependent chronic neutrophilia during mycobacterial infections. Clin Exp Immunol (1989) 1.56
Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med (2005) 1.47
MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J Autoimmun (2008) 1.42
Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity. J Infect Dis (2006) 1.30
Long pentraxin 3 in pulmonary infection and acute lung injury. Am J Physiol Lung Cell Mol Physiol (2007) 1.29
Genomic and molecular profiling predicts response to temozolomide in melanoma. Clin Cancer Res (2009) 1.26
Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma. Nat Immunol (2009) 1.25
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur Respir J (2008) 1.22
Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology (2007) 1.15
Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis. Infect Immun (2002) 1.09
Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity. Microbes Infect (2009) 1.09
Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis. Microbes Infect (2005) 1.08
Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease. Am J Respir Cell Mol Biol (2008) 1.08
A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of Mycobacterium tuberculosis pulmonary infection. Tuberculosis (Edinb) (2004) 1.04
Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity. Am J Pathol (2008) 1.02
Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation? Cytokine Growth Factor Rev (2004) 1.01
Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant. Clin Vaccine Immunol (2010) 1.01
Cellular expression of murine Ym1 and Ym2, chitinase family proteins, as revealed by in situ hybridization and immunohistochemistry. Histochem Cell Biol (2004) 0.99
TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. Blood (2008) 0.97
Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis. Infect Immun (2003) 0.96
Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL/6 mouse model. Clin Vaccine Immunol (2008) 0.95
Major basic protein homolog (MBP2): a specific human eosinophil marker. J Immunol (2006) 0.95
Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array. Clin Vaccine Immunol (2008) 0.94
Human neutrophil alloantigens systems. An Acad Bras Cienc (2009) 0.93
Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family. Vaccine (2005) 0.93
Proteoglycans in granulomatous lung diseases. Eur Respir J (1997) 0.92
Matrilysin (Matrix Metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(E)beta(7)-integrin). Am J Pathol (2009) 0.90
Vaccination of animals against Mycobacterium bovis. Rev Sci Tech (2001) 0.90
Cathepsin G: roles in antigen presentation and beyond. Mol Immunol (2009) 0.89
Development of a Mycobacterium bovis intranasal challenge model in mice. Tuberculosis (Edinb) (2008) 0.86
Potential correlates of BCG induced protection against tuberculosis detected in a mouse aerosol model using gene expression profiling. Tuberculosis (Edinb) (2006) 0.81
Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis. Infect Immun (2004) 1.71
Bovine tuberculosis vaccine research: historical perspectives and recent advances. Vaccine (2012) 1.59
A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect Immun (2003) 1.42
Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complex. Infect Immun (2008) 1.27
Infection biology of a novel alpha-crystallin of Mycobacterium tuberculosis: Acr2. J Immunol (2005) 1.23
Minimum infective dose of Mycobacterium bovis in cattle. Infect Immun (2005) 1.22
Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves. Vaccine (2009) 1.22
Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, The Netherlands and Germany. PLoS One (2013) 1.18
Screening of predicted secreted antigens from Mycobacterium bovis reveals the immunodominance of the ESAT-6 protein family. Infect Immun (2010) 1.15
Recent advances in our knowledge of Mycobacterium bovis: a feeling for the organism. Vet Microbiol (2005) 1.13
Bovine tuberculosis in Europe from the perspective of an officially tuberculosis free country: trade, surveillance and diagnostics. Vet Microbiol (2011) 1.13
Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine (2005) 1.11
Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 T(EM) cells which expand following virulent mycobacterial challenge. PLoS One (2011) 1.08
Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis. Vet Immunol Immunopathol (2007) 1.06
Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines. Curr Gene Ther (2005) 1.04
Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations. Vaccine (2007) 1.01
Cattle as a model for development of vaccines against human tuberculosis. Tuberculosis (Edinb) (2004) 0.98
Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone. Clin Vaccine Immunol (2008) 0.96
Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids. Infect Immun (2005) 0.95
Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae. Clin Vaccine Immunol (2011) 0.94
Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family. Vaccine (2005) 0.93
Bovine tuberculosis: effect of the tuberculin skin test on in vitro interferon gamma responses. Vet Immunol Immunopathol (2010) 0.93
Global gene transcriptome analysis in vaccinated cattle revealed a dominant role of IL-22 for protection against bovine tuberculosis. PLoS Pathog (2012) 0.92
Simultaneous measurement of antigen-stimulated interleukin-1 beta and gamma interferon production enhances test sensitivity for the detection of Mycobacterium bovis infection in cattle. Clin Vaccine Immunol (2010) 0.92
Enhancement of the sensitivity of the whole-blood gamma interferon assay for diagnosis of Mycobacterium bovis infections in cattle. Clin Vaccine Immunol (2007) 0.91
Development of an antibody to bovine IL-2 reveals multifunctional CD4 T(EM) cells in cattle naturally infected with bovine tuberculosis. PLoS One (2011) 0.91
Optimization of a whole-blood gamma interferon assay for detection of Mycobacterium bovis-infected cattle. Clin Vaccine Immunol (2009) 0.90
Bioinformatic and empirical analysis of novel hypoxia-inducible targets of the human antituberculosis T cell response. J Immunol (2012) 0.90
Improved skin test for differential diagnosis of bovine tuberculosis by the addition of Rv3020c-derived peptides. Clin Vaccine Immunol (2012) 0.89
Goats primed with Mycobacterium bovis BCG and boosted with a recombinant adenovirus expressing Ag85A show enhanced protection against tuberculosis. Clin Vaccine Immunol (2012) 0.88
Performance of the Enferplex TB assay with cattle in Great Britain and assessment of its suitability as a test to distinguish infected and vaccinated animals. Clin Vaccine Immunol (2010) 0.88
Diagnostic value of animal-side antibody assays for rapid detection of Mycobacterium bovis or Mycobacterium microti infection in South American camelids. Clin Vaccine Immunol (2011) 0.88
Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers. PLoS One (2012) 0.87
Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis. Vaccine (2005) 0.87
Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model. Clin Vaccine Immunol (2009) 0.86
Development of a Mycobacterium bovis intranasal challenge model in mice. Tuberculosis (Edinb) (2008) 0.86
A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progression. PLoS One (2013) 0.86
Use of antigen-specific interleukin-2 to differentiate between cattle vaccinated with Mycobacterium bovis BCG and cattle infected with M. bovis. Clin Vaccine Immunol (2013) 0.84
Differential effects of Mycobacterium bovis--derived polar and apolar lipid fractions on bovine innate immune cells. Vet Res (2012) 0.83
Screening of predicted secreted antigens from Mycobacterium bovis identifies potential novel differential diagnostic reagents. Clin Vaccine Immunol (2010) 0.83
Vaccines for bovine tuberculosis: current views and future prospects. Expert Rev Vaccines (2005) 0.83
Update on vaccination of cattle and wildlife populations against tuberculosis. Vet Microbiol (2011) 0.83
Immunogenicity comparison of the intradermal or endobronchial boosting of BCG vaccinates with Ad5-85A. Vaccine (2012) 0.82
Effects of vaccination against paratuberculosis on tuberculosis in goats: diagnostic interferences and cross-protection. BMC Vet Res (2012) 0.82
Assessment of Mycobacterium tuberculosis OmpATb as a novel antigen for the diagnosis of bovine tuberculosis. Clin Vaccine Immunol (2009) 0.81
Is interleukin-4delta3 splice variant expression in bovine tuberculosis a marker of protective immunity? Infect Immun (2007) 0.81
Characterization of two in vivo-expressed methyltransferases of the Mycobacterium tuberculosis complex: antigenicity and genetic regulation. Microbiology (2008) 0.81
Immune responses to the enduring hypoxic response antigen Rv0188 are preferentially detected in Mycobacterium bovis infected cattle with low pathology. PLoS One (2011) 0.81
The use of binding-prediction models to identify M. bovis-specific antigenic peptides for screening assays in bovine tuberculosis. Vet Immunol Immunopathol (2011) 0.80
Vaccines designed to protect against Mycobacterium tuberculosis infection may aid the identification of novel vaccine constructs and diagnostic antigens for bovine tuberculosis. Vet Microbiol (2010) 0.80
Low oral BCG doses fail to protect cattle against an experimental challenge with Mycobacterium bovis. Tuberculosis (Edinb) (2011) 0.78
The duration of antigen-stimulation significantly alters the diversity of multifunctional CD4 T cells measured by intracellular cytokine staining. PLoS One (2012) 0.77
Development of an unbiased antigen-mining approach to identify novel vaccine antigens and diagnostic reagents for bovine tuberculosis. Clin Vaccine Immunol (2013) 0.76
Signal regulatory protein alpha (SIRPalpha) cells in the adaptive response to ESAT-6/CFP-10 protein of tuberculous mycobacteria. PLoS One (2009) 0.76
Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattle. Vaccine (2013) 0.75
Experimental Infection Models of Tuberculosis in Domestic Livestock. Microbiol Spectr (2016) 0.75
Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines. Vet Immunol Immunopathol (2011) 0.75